Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Variants in Individuals Evaluated for Primary Ciliary Dyskinesia.

[1]  M. Rosenfeld,et al.  Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.

[2]  Joshua S. Paul,et al.  Prevalence and properties of intragenic copy-number variation in Mendelian disease genes , 2018, Genetics in Medicine.

[3]  G. Cutting,et al.  Functional Assays Are Essential for Interpretation of Missense Variants Associated with Variable Expressivity. , 2018, American journal of human genetics.

[4]  R. Gibson,et al.  Variation in Cilia Protein Genes and Progression of Lung Disease in Cystic Fibrosis , 2018, Annals of the American Thoracic Society.

[5]  Keith Nykamp,et al.  Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria , 2017, Genetics in Medicine.

[6]  C. Castellani,et al.  Cystic Fibrosis Diagnostic Challenges over 4 Decades: Historical Perspectives and Lessons Learned , 2017, The Journal of pediatrics.

[7]  R. Parad,et al.  Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length. , 2016, Genetic testing and molecular biomarkers.

[8]  R. Dahl,et al.  Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis. , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[9]  N. Simmonds,et al.  Phenotypic variability of R117H-CFTR expression within monozygotic twins. , 2016, Paediatric respiratory reviews.

[10]  M. Rosenfeld,et al.  Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review , 2015, Pediatric pulmonology.

[11]  H. Omran,et al.  Ciliary function and motor protein composition of human fallopian tubes. , 2015, Human reproduction.

[12]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[13]  Garry R. Cutting,et al.  Cystic fibrosis genetics: from molecular understanding to clinical application , 2014, Nature Reviews Genetics.

[14]  D. Manson,et al.  Primary Ciliary Dyskinesia and Neonatal Respiratory Distress , 2014, Pediatrics.

[15]  L. A. Daniels,et al.  Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. , 2013, American journal of respiratory and critical care medicine.

[16]  George P Patrinos,et al.  Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene , 2013, Nature Genetics.

[17]  J. Nobel,et al.  Assessment of CFTR function in homozygous R117H-7T subjects. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[18]  B. Kerem,et al.  Recommendations for the classification of diseases as CFTR-related disorders. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[19]  K. Hörmann,et al.  ENT manifestations in patients with primary ciliary dyskinesia: prevalence and significance of otorhinolaryngologic co-morbidities , 2011, European Archives of Oto-Rhino-Laryngology.

[20]  E. Ziętkiewicz,et al.  Carrier status for 3 most frequentCFTR mutations in Polish PCD/KS patients: lack of association with the primary ciliary dyskinesia phenotype , 2010, Journal of Applied Genetics.

[21]  E. Génin,et al.  The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening , 2009, Journal of Medical Genetics.

[22]  S. Paranjape,et al.  Atypical Cystic Fibrosis and CFTR-Related Diseases , 2008, Clinical reviews in allergy & immunology.

[23]  Aubrey Milunsky,et al.  CFTR 5T variant has a low penetrance in females that is partially attributable to its haplotype , 2006, Genetics in Medicine.

[24]  M. Hazucha,et al.  Primary ciliary dyskinesia: diagnostic and phenotypic features. , 2004, American journal of respiratory and critical care medicine.

[25]  Xavier Estivill,et al.  Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. , 2004, American journal of human genetics.

[26]  M. Knowles,et al.  Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.

[27]  Min Goo Lee,et al.  Aberrant CFTR-dependent HCO-3 transport in mutations associated with cystic fibrosis , 2001, Nature.

[28]  E. Buratti,et al.  Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. , 1999, Human molecular genetics.

[29]  M. Goossens,et al.  Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. , 1998, The Journal of clinical investigation.

[30]  M. Greenstone,et al.  Fertility in men with primary ciliary dyskinesia presenting with respiratory infection. , 1994, Thorax.

[31]  M. Welsh,et al.  Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels , 1993, Nature Genetics.

[32]  M. Welsh,et al.  Mutations in CFTR associated with mild-disease-form CI- channels with altered pore properties , 1993, Nature.

[33]  J. Wilson,et al.  Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance. , 1993, Human molecular genetics.